Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07301385 · ClinicalTrials.gov registry record · NA
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
A NA study of Cataract and Cataract Surgery, sponsored by Sharp HealthCare.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07301385: Recruiting NA study of Cataract and Cataract Surgery, sponsored by Sharp HealthCare.
NCT07301385 is a NA study of Cataract and Cataract Surgery that is actively recruiting participants, run by Sharp HealthCare. The registered enrollment target is 30 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07301385, a NA study of Cataract and Cataract Surgery, is actively recruiting participants, sponsored by Sharp HealthCare.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate the use of the research study device, the Apple Vision Pro head-mounted spatial computing display, with the Zeiss Artevo 850 digital microscope system, for the visualization during cataract and anterior segment surgery. Specifically, researchers will assess how the study device affects surgical staff experience and workflow and monitor for patient safety and intraoperative complications associated with the use of the device.
Primary Outcome
Safety will be assessed by the proportion of surgical cases completed using head-mounted spatial computing visualization without conversion to standard microscope visualization due to device-related issues, and by the occurrence of intraoperative complications potentially related to visualization, including posterior capsule rupture, vitreous loss, corneal or scleral injury, or other unplanned intraoperative events.
Conditions Studied
Interventions
- DEVICE Apple Vision Pro (Head-Mounted Spatial Computing Display)
- DEVICE Zeiss Artevo Digital Surgical Microscope
Study Locations (1)
California
- Sharp Otay Lakes Surgery Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-03-11 |
| Est. Completion | 2026-09-10 |
| Phase | NA |
What NCT07301385 shows while recruiting
NCT07301385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which Apple Vision Pro (Head-Mounted Spatial Computing Display) is the first listed.
NCT07301385 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07301385 about?
NCT07301385 is a clinical study titled "Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study". The purpose of this research is to evaluate the use of the research study device, the Apple Vision Pro head-mounted spatial computing display, with the Zeiss Artevo 850 digital microscope system, for the visualization during cataract and anterior segment surgery. Specifically, researchers will asses...
What is the current status of trial NCT07301385?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03-11. Estimated completion is 2026-09-10.
What conditions does trial NCT07301385 study?
This clinical trial studies the following conditions: Cataract, Cataract Surgery.
What interventions are being tested in trial NCT07301385?
The interventions under investigation include: Apple Vision Pro (Head-Mounted Spatial Computing Display) (DEVICE), Zeiss Artevo Digital Surgical Microscope (DEVICE).
Who is sponsoring clinical trial NCT07301385?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07301385 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07301385's enrollment target sits among peer trials
30 73rd of 83 higher than 9 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
-
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI